Kainos Laboratories, Inc. operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kainos Laboratories with three other
pharmaceutical manufacturers in Asia:
BioSino Bio-technology and Science Inc
sales of 303.22 million Chinese Renmimbi [US$45.18 million]
(362.64 million Chinese Renmimbi [US$54.03 million]
OK Biotech Co Ltd
based in Taiwan
(1.12 billion Taiwanese Dollars [US$36.31 million]
During the year ended March of 2018, sales at
Kainos Laboratories were ¥4.39 billion (US$39.17 million).
decrease of 6.7%
versus 2017, when the company's sales were ¥4.70 billion.